Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. News
  3. pharmaceutical api research
Show results for
Products
Services
Software
Training
Applications

Companies

News
Articles
Downloads
Videos

Refine by
Date

  • Older

Pharmaceutical Api Research Articles & Analysis: Older

146 news found

Profacgen Updates Its Antimicrobial Peptides Services to Drive Innovation in Antimicrobial Research

Profacgen Updates Its Antimicrobial Peptides Services to Drive Innovation in Antimicrobial Research

Profacgen, a leading provider of custom biotechnology services, is pleased to announce significant updates to its Antimicrobial Peptides (AMPs) Services, enhancing its capabilities to support the growing demand for alternative therapies in the fight against drug-resistant pathogens. As antibiotic resistance continues to pose a global health threat, Profacgen is expanding its services to assist ...

ByProfacgen


Ace Therapeutics Releases Cardiovascular Disease Model Development Services to Power Up Related Preclinical Research

Ace Therapeutics Releases Cardiovascular Disease Model Development Services to Power Up Related Preclinical Research

Ace Therapeutics is proud to announce the launch of its cardiovascular disease model development services, aiming to empower researchers and pharmaceutical companies with advanced tools and models to accelerate the study of cardiovascular diseases and drug discovery. Cardiovascular disease (CVD) remains a leading cause of morbidity and mortality worldwide, underscoring the urgent need for ...

ByAce Therapeutics


Ace Therapeutics Launches Gene Therapy Development Services to Unleash Glaucoma Drug Research

Ace Therapeutics Launches Gene Therapy Development Services to Unleash Glaucoma Drug Research

Ace Therapeutics is excited to announce the launch of its groundbreaking glaucoma gene therapy development services. This new initiative is set to advance research in glaucoma treatments, offering comprehensive support and innovation for researchers and pharmaceutical companies aiming to cure this pervasive eye disease. Glaucoma is a group of eye conditions that damage the optic nerve, often ...

ByAce Therapeutics


Protheragen-ING AI-Pharma’s AI-Powered Drug Discovery and Design Platform—A Paradigm Shift in Drug Development

Protheragen-ING AI-Pharma’s AI-Powered Drug Discovery and Design Platform—A Paradigm Shift in Drug Development

In the ever-evolving landscape of pharmaceutical research and development, the demand for innovative and efficient drug discovery methods is more pressing than ever. At the forefront of this demanding field is Protheragen-ING AI-Pharma, a contract research and development biotechnology company, offering cutting-edge solutions to researchers through its AI-powered drug discovery and design ...

ByProtheragen-ING


Veolia Water Technologies launches mobile water services to support pharmaceutical and life science companies in Europe

Veolia Water Technologies launches mobile water services to support pharmaceutical and life science companies in Europe

Veolia Water Technologies has launched its mobile water services offering to the pharmaceutical, cosmetics and life science industries across Europe. This initiative provides a comprehensive range of technologies and services bundled as a rental service to deliver reliable, uninterrupted and sustainable solutions for manufacturing, cleaning, and complex liquid waste treatment for compliant ...

ByVeolia Water Technologies


Ace Therapeutics Accelerates Preclinical GI and Hepatology Research with Disease Model Customization Services

Ace Therapeutics Accelerates Preclinical GI and Hepatology Research with Disease Model Customization Services

Ace Therapeutics is a preclinical contract research provider engaged in metabolic disorders, infectious diseases and parasites, neurological disorders, ophthalmic diseases, gastrointestinal disorders, and immune system diseases. Following with the announcement of developing small molecule drug for glaucoma, Ace Therapeutics recently unveiled disease model customization services to accelerate ...

ByAce Therapeutics


Creative Enzymes Unveils Semaglutide, a Promising Solution for Comprehensive Diabetes Management

Creative Enzymes Unveils Semaglutide, a Promising Solution for Comprehensive Diabetes Management

Creative Enzymes, a leading provider of high-quality enzymes and biochemicals, is proud to announce the addition of Semaglutide to its comprehensive product portfolio. This novel glucagon-like peptide-1 (GLP-1) receptor agonist has generated significant excitement within the pharmaceutical and life sciences industries due to its remarkable efficacy in managing type 2 diabetes. Semaglutide ...

ByCreative Enzymes


Ace Therapeutics Announces Vaccine Development Services Against Superbugs

Ace Therapeutics Announces Vaccine Development Services Against Superbugs

Ace Therapeutics is a preclinical contract research provider engaged in metabolic disorders, infectious diseases and parasites, neurological disorders, ophthalmic diseases, gastrointestinal disorders, and immune system diseases. With the rise of antibiotic-resistant bacteria posing a significant threat to global public health, Ace Therapeutics announces its new vaccine development services to ...

ByAce Therapeutics


Huateng Pharma Introduces Y-Shape PEG NHS

Huateng Pharma Introduces Y-Shape PEG NHS

Huateng Pharma, a global leader in PEG derivatives and a premier CDMO for APIs and intermediates, is excited to announce the launch of its latest product, Y-Shape PEG NHS. This cutting-edge Succinimidyl Carboxymethyl Ester branched 2ARM PEG offers a revolutionary approach to amine PEGylation, enhancing the modification of proteins and other biologics. PEGylation, the technique of attaching a PEG ...

ByHunan Huateng Pharmaceutical Co. Ltd.


CD Bioparticles Simplifies Multi-Analyte Detection with Advanced Multiplex Particles

CD Bioparticles Simplifies Multi-Analyte Detection with Advanced Multiplex Particles

With years of experience in the pharmaceutical and life science sectors, CD Bioparticles announces its advanced line of multiplex fluorescence particles designed to streamline complex biological assays in flow cytometry experiments. These particles exhibit low signal widths in the forward scatter, side scatter and fluorescence channels. Various surface modifications, channels and sizes are also ...

ByCD Bioparticles


CD ComputaBio Revolutionizes Drug Discovery with Cutting-Edge Computer-Aided Drug Design Services   

CD ComputaBio Revolutionizes Drug Discovery with Cutting-Edge Computer-Aided Drug Design Services  

CD ComputaBio, a pioneering provider of computational biology services, has recently introduced its advanced Computer-Aided Drug Design (CADD) services, revolutionizing the drug discovery landscape. Through the utilization of cutting-edge computational chemistry techniques, CD ComputaBio aims to streamline and enhance the process of drug discovery for pharmaceutical companies, research ...

ByCD ComputaBio


Huateng Pharmace to Showcase Innovations at CPHI China 2024

Huateng Pharmace to Showcase Innovations at CPHI China 2024

Shanghai, China – June 14, 2024 – Hunan Huateng Pharmaceutical Co., Ltd., a global leader in the production of PEG derivatives and Contract Development and Manufacturing Organization (CDMO) services for Active Pharmaceutical Ingredients (APIs) and intermediates, is excited to announce its participation in CPHI China 2024. The event will take place from June 19 to 21, 2024, at the Shanghai New ...

ByHunan Huateng Pharmaceutical Co. Ltd.


Protheragen-ING Announces Participation in 26th SAPA-NE Annual Conference   

Protheragen-ING Announces Participation in 26th SAPA-NE Annual Conference  

[Cambridge, June 8, 2024] Protheragen-ING is pleased to announce its participation in the 26th SAPA-NE Annual Conference. The event will be held at the Cambridge Marriott Boston (50 Broadway, Cambridge, MA 02142), on June 8, 2024, 9 am - 5 pm EDT. About SAPA-NE SAPA (Sino-American Pharmaceutical Professionals Association) is one of the most active and largest Chinese-based biopharmaceutical ...

ByProtheragen-ING


CD Formulation Offers Robust Expertise in Pharmacology to Aid Veterinary Drug Development

CD Formulation Offers Robust Expertise in Pharmacology to Aid Veterinary Drug Development

CD Formulation, an expert in the pharmaceutical research and development field, has announced the expansion of its comprehensive pharmacological services to support the burgeoning sector of veterinary drugs. The move is poised to elevate the standard and efficacy of veterinary pharmaceuticals, reinforcing CD Formulation’s dedication to the well-being of animals globally. “Our ...

ByCD Formulation


Alfa Chemistry Expands Inventory with New Range of Phosphine Ligands, Nitrogen-Donor Ligands, and Oxygen-Donor Ligands

Alfa Chemistry Expands Inventory with New Range of Phosphine Ligands, Nitrogen-Donor Ligands, and Oxygen-Donor Ligands

In a major development poised to benefit the scientific community, Alfa Chemistry has recently unveiled an expanded catalog featuring an extensive range of phosphine ligands, nitrogen-donor ligands, and oxygen-donor ligands. This addition underscores the company's commitment to providing high-quality chemical reagents and catalysts to enhance research and industrial processes across various ...

ByAlfa Chemistry


Alfa Chemistry Newly Releases Varieties of Halide Quaternary Ammonium Salts: Fluoride, Chloride, Bromide, Iodide Series Included

Alfa Chemistry Newly Releases Varieties of Halide Quaternary Ammonium Salts: Fluoride, Chloride, Bromide, Iodide Series Included

Alfa Chemistry, a renowned chemical supplier, has recently unveiled a wide range of halide quaternary ammonium salts, encompassing fluoride, chloride, bromide, and iodide series. These newly released products are aimed to meet the increasing demands of various industries for high-quality chemicals. With a history of providing top-notch chemical products, Alfa Chemistry has established itself as a ...

ByAlfa Chemistry


CD Formulation Develops, Evaluates, and Utilizes Innovative Drug Delivery Technologies for the Pharmaceutical Industry   

CD Formulation Develops, Evaluates, and Utilizes Innovative Drug Delivery Technologies for the Pharmaceutical Industry  

CD Formulation is making waves in the pharmaceutical industry with its innovative drug delivery technologies. With a focus on sustained and controlled release formulations, as well as liquid, semi-solid, injectable, and nanoformulations, CD Formulation is at the forefront of the industry's efforts to enhance drug efficacy. One of CD Formulation's key technology platforms is its sustained ...

ByCD Formulation


CD Bioparticles Introduces New Polyolefin Family Polymers for Drug Delivery Applications

CD Bioparticles Introduces New Polyolefin Family Polymers for Drug Delivery Applications

CD Bioparticles, a leading manufacturer and supplier of numerous drug delivery products and services, has recently expanded its low PDI polymer portfolio and announces its new offering of Polyolefin Family polymers with a wide range of properties that make them well-suited for a variety of drug delivery applications. Low dispersion index polymers are polymeric compounds with low molecular weight ...

ByCD Bioparticles


Alfa Chemistry Expands Selection of Click Chemistry Reagents: DBCO, BCN, and Tetrazines Included   

Alfa Chemistry Expands Selection of Click Chemistry Reagents: DBCO, BCN, and Tetrazines Included  

Alfa Chemistry, a leading chemical supplier and service provider, has recently announced the expansion of their selection of click chemistry reagents. This development aims to better serve the needs of researchers and scientists working in the field of click chemistry, a powerful method for assembling complex molecular structures quickly and efficiently. Click chemistry has gained significant ...

ByAlfa Chemistry


CD Formulation Unveils Prominent Pharmaceutical Ingredients and Excipients for Enhanced Medicine Efficacy   

CD Formulation Unveils Prominent Pharmaceutical Ingredients and Excipients for Enhanced Medicine Efficacy  

In the quest to develop safe and effective medicines, pharmaceutical companies rely on the precise combination of active pharmaceutical ingredients (APIs) and excipients. ...

ByCD Formulation

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical XPRT Industry Products
  • Medical XPRT Industry Software
  • Medical XPRT Industry Training
  • Medical XPRT Industry Services
  • Medical XPRT Industry Applications

Latest

  • Medical XPRT Industry News
  • Medical XPRT Industry Events

Publications

  • Medical XPRT Industry Articles
  • Medical XPRT Industry Books
  • Medical XPRT Industry Magazines
  • Medical XPRT Industry Downloads
  • Medical XPRT Industry Videos

Companies

  • Medical XPRT Industry Companies

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT